Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas Rex

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.

Original languageEnglish (US)
JournalGastroenterology
DOIs
StateAccepted/In press - 2016

Fingerprint

Occult Blood
Hematologic Tests
Advisory Committees
Early Detection of Cancer
Colorectal Neoplasms
Neoplasms
Hemoglobins
Guidelines

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia : A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. / Robertson, Douglas J.; Lee, Jeffrey K.; Boland, C. Richard; Dominitz, Jason A.; Giardiello, Francis M.; Johnson, David A.; Kaltenbach, Tonya; Lieberman, David; Levin, Theodore R.; Rex, Douglas.

In: Gastroenterology, 2016.

Research output: Contribution to journalArticle

Robertson, Douglas J. ; Lee, Jeffrey K. ; Boland, C. Richard ; Dominitz, Jason A. ; Giardiello, Francis M. ; Johnson, David A. ; Kaltenbach, Tonya ; Lieberman, David ; Levin, Theodore R. ; Rex, Douglas. / Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia : A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. In: Gastroenterology. 2016.
@article{930f540d274b4a6996b41c3a6b04927d,
title = "Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer",
abstract = "The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.",
author = "Robertson, {Douglas J.} and Lee, {Jeffrey K.} and Boland, {C. Richard} and Dominitz, {Jason A.} and Giardiello, {Francis M.} and Johnson, {David A.} and Tonya Kaltenbach and David Lieberman and Levin, {Theodore R.} and Douglas Rex",
year = "2016",
doi = "10.1053/j.gastro.2016.08.053",
language = "English (US)",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia

T2 - A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

AU - Robertson, Douglas J.

AU - Lee, Jeffrey K.

AU - Boland, C. Richard

AU - Dominitz, Jason A.

AU - Giardiello, Francis M.

AU - Johnson, David A.

AU - Kaltenbach, Tonya

AU - Lieberman, David

AU - Levin, Theodore R.

AU - Rex, Douglas

PY - 2016

Y1 - 2016

N2 - The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.

AB - The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.

UR - http://www.scopus.com/inward/record.url?scp=85008629253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008629253&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2016.08.053

DO - 10.1053/j.gastro.2016.08.053

M3 - Article

C2 - 27769517

AN - SCOPUS:85008629253

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

ER -